Skip to main content

Camac Fund, LP's Form 4 filing

Pasithea Therapeutics Corp.KTTA · filed Aug 31, 2022

Accession no.
0001209191-22-048135
Filed
Aug 31, 2022, 4:32 PM ET
Trade date
Aug 29-30, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market purchases total $26.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Camac Fund, LPCIK 0001516478Other: Member of 10% owner group
Shahinian EricCIK 0001790877Other: Member of 10% owner group
Camac Partners, LLCCIK 0001867496Other: Member of 10% owner group
Camac Capital, LLCCIK 0001867498Other: Member of 10% owner group

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 29, 2022Common StockPPurchaseAcquired+5,000$1.17+$5,840.51,617,329Indirect
Aug 30, 2022Common StockPPurchaseAcquired+17,828$1.15+$20,452.281,635,157Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)